Depression studies

Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models

This study is by invitation only.

Countries

United States

Sponsor

Psyrin Inc.

Mindfulness-Based Therapy for Serious Mental Illness

This study is by invitation only.

Countries

United States

Sponsor

Butler Hospital

Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects

This study is by invitation only.

Countries

China

Sponsor

Luye Pharma Group Ltd.

A multicentre study to assess safety and efficacy of psilocybin in patients with treatment-resistant depression following completion of COMP 001 and COMP 003 trials (P-TRD LTFU)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Czechia, Denmark, Germany, + 2 others

Sponsor

COMPASS Pathways, Ltd

A 52-Week Open-Label Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

United Kingdom, Finland, Poland, + 1 other

Sponsor

ACADIA Pharmaceuticals Inc

A randomised controlled trial of oral S-ketamine as add-on medication for patients with treatment-resistant major depressive disorder

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Netherlands

Sponsor

University Medical Centre Groningen

A randomised, placebo-controlled, double-blind trial of the antidepressant efficacy of a novel CNS-penetrant P2X7 receptor antagonist, JNJ-54175446, in people with major depressive disorder, an inc...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

United Kingdom

Sponsor

Cambridgeshire and Peterborough NHS Foundation Trust and University of Cambridge

BRAIN DERIVED NEUROTROPHIC FACTOR AND MAJOR DEPRESSIVE DISORDER TREATMENT: CLINICAL PSYCHOLOGICAL AND PSYCHOPHARMACOTHERAPIC EVALUATIONS

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Italy

Sponsor

AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO"

Comparing Problem Solving Treatment combined with duloxetine with Problem Solving Treatment alone for patients with major depressive disorder in primary care

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Netherlands

Sponsor

Eli Lilly Nederland

Double-Blind, Placebo-Controlled, Multi-Center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-61393215 as Adjunctive Treatment in Adults with Major Depressive Disorder with Anxio...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

United Kingdom

Sponsor

Janssen-Cilag International NV

The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression (P-TRD)

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

United Kingdom, Czechia, Denmark, + 5 others

Sponsor

COMPASS Pathways, Ltd

Collaborative stepped care for adults with depressive symptoms in primary care

Countries

China

Sponsor

The University of Hong Kong